* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Monday, September 1, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    Country music star apologizes after drunken show ends with cops taking him down: ‘I’m not OK’ – PennLive.com

    Country Music Star Apologizes After Drunken Show Ends in Police Intervention: ‘I’m Not OK

    Comanche Nation Entertainment closes casino near Devol – KSWO 7News

    Comanche Nation Entertainment Closes Casino Near Devol in Surprising Move

    Erykah Badu Announces ‘Abi & Alan’ Album With The Alchemist Will Be Delayed – yahoo.com

    Erykah Badu Opens Up About the Delay of Her Highly Anticipated ‘Abi & Alan’ Album with The Alchemist

    If You Needed Some BTS Pics Of The Rock’s Tree Trunk Legs To Spice Up Your Day, We Got ‘Em – yahoo.com

    Need a Boost? Check Out These Epic BTS Shots of The Rock’s Tree Trunk Legs!

    Sabrina Carpenter’s pearl-clutching magic? Humor – CNN

    Sabrina Carpenter’s pearl-clutching magic? Humor – CNN

    South Park Is In Trouble And Needs To Change Course, Fast – yahoo.com

    South Park Faces Major Challenges and Must Adapt Fast to Survive

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    This Secret Technology Will Make The IPhone 17 Super Thin Air – VOI.ID

    How This Breakthrough Technology Will Make the iPhone 17 Incredibly Thin and Lightweight

    Gator football kicks off with excitement and new technology – WCJB | TV20

    Gator Football Kicks Off with Thrilling Action and Innovative Technology

    Marvell Technology (MRVL) Loses 18.6% as Growth Outlook Fails to Impress – Yahoo Finance

    Marvell Technology (MRVL) Loses 18.6% as Growth Outlook Fails to Impress – Yahoo Finance

    Propelling solar technology into a perovskite future – CORDIS

    Propelling solar technology into a perovskite future – CORDIS

    13 Top Technology Trends (2025) – Exploding Topics

    13 Game-Changing Technology Trends to Watch in 2025

    Japan’s legacy LCD and chip technology find new home in India – Nikkei Asia

    How Japan’s Breakthrough LCD and Chip Technologies Are Driving Innovation in India

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    Country music star apologizes after drunken show ends with cops taking him down: ‘I’m not OK’ – PennLive.com

    Country Music Star Apologizes After Drunken Show Ends in Police Intervention: ‘I’m Not OK

    Comanche Nation Entertainment closes casino near Devol – KSWO 7News

    Comanche Nation Entertainment Closes Casino Near Devol in Surprising Move

    Erykah Badu Announces ‘Abi & Alan’ Album With The Alchemist Will Be Delayed – yahoo.com

    Erykah Badu Opens Up About the Delay of Her Highly Anticipated ‘Abi & Alan’ Album with The Alchemist

    If You Needed Some BTS Pics Of The Rock’s Tree Trunk Legs To Spice Up Your Day, We Got ‘Em – yahoo.com

    Need a Boost? Check Out These Epic BTS Shots of The Rock’s Tree Trunk Legs!

    Sabrina Carpenter’s pearl-clutching magic? Humor – CNN

    Sabrina Carpenter’s pearl-clutching magic? Humor – CNN

    South Park Is In Trouble And Needs To Change Course, Fast – yahoo.com

    South Park Faces Major Challenges and Must Adapt Fast to Survive

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    This Secret Technology Will Make The IPhone 17 Super Thin Air – VOI.ID

    How This Breakthrough Technology Will Make the iPhone 17 Incredibly Thin and Lightweight

    Gator football kicks off with excitement and new technology – WCJB | TV20

    Gator Football Kicks Off with Thrilling Action and Innovative Technology

    Marvell Technology (MRVL) Loses 18.6% as Growth Outlook Fails to Impress – Yahoo Finance

    Marvell Technology (MRVL) Loses 18.6% as Growth Outlook Fails to Impress – Yahoo Finance

    Propelling solar technology into a perovskite future – CORDIS

    Propelling solar technology into a perovskite future – CORDIS

    13 Top Technology Trends (2025) – Exploding Topics

    13 Game-Changing Technology Trends to Watch in 2025

    Japan’s legacy LCD and chip technology find new home in India – Nikkei Asia

    How Japan’s Breakthrough LCD and Chip Technologies Are Driving Innovation in India

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Health

Semaglutide Significantly Improves Chronic Kidney Disease

May 26, 2024
in Health
Semaglutide Significantly Improves Chronic Kidney Disease
Share on FacebookShare on Twitter

STOCKHOLM — Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has shown significant benefits in preventing major kidney disease, cardiovascular events, as well as mortality in patients with chronic kidney disease (CKD) and type 2 diabetes in the landmark FLOW trial.

“This is the first trial that’s specifically asked the question of whether this class of drugs — GLP-1 receptor agonists — protects the kidney and prevents major kidney outcomes, and the results clearly showed that that’s the case,” lead author Vlado Perkovic, MBBS, PhD, dean of medicine and health and scientia professor at UNSW Sydney, Australia, told Medscape Medical News.

Based on the results, “we anticipate that regulatory agencies and guidelines would incorporate this into the label for the drug and into all guidelines as the recommended care for people with diabetic kidney disease,” he said.

As reiterated by several speakers during the full session devoted to the groundbreaking study held on May 24 here at the 61st European Renal Association (ERA) Congress, the data suggest the addition of semaglutide as a fourth pillar to the guideline-recommended pillars of treatment for CKD and diabetes.

“The four pillars are now a renin-angiotensin-aldosterone system (RAAS) blocker, sodium-glucose cotransporter-2 (SGLT2) inhibitors, finerenone, and semaglutide,” said study co-author Katherine R. Tuttle, MD, who is a professor of medicine, Nephrology Division and Kidney Research Institute, at the University of Washington, Seattle, while presenting the findings.

The study was simultaneously published in the New England Journal of Medicine.

With a variety of kidney benefits of semaglutide shown in numerous clinical trials and regularly reported in clinical practice, the double-blind, international FLOW (Evaluate Renal Function With Semaglutide Once Weekly) trial was conducted to take on the issue with kidney measures in patients with CKD as a primary outcome.

The study, conducted in 28 countries, involved 3533 patients recruited between June 2019 and May 2021 who had CKD and type 2 diabetes. Patients were randomized to treatment with semaglutide 1.0 mg once weekly (n=1767) or placebo (n=1766), both in addition to standard care.

Patients were a mean age of about 66 years, about 30% were female, and about 66% were White.

Importantly, the study included high-risk patients, with 93% having high or very high-risk CKD, based on Kidney Disease: Improving Global Outcomes (KDIGO) criteria.

In addition, about 95% of patients were receiving a RAAS blocker, about 60% were receiving an angiotensin II receptor blocker (ARB), about 35% were receiving an angiotensin-converting enzyme (ACE) inhibitor, and as many as 80% were receiving lipid-lowering drugs.

About 15% were receiving an SGLT2 inhibitor, reflecting the time period when enrollment occurred (before increased use of the drugs).

A prespecified interim analysis clearly showed the efficacy of semaglutide, and therefore, the independent data and safety monitoring committee recommended the trial be stopped early.

With a median follow-up of 3.4 years, the results showed that patients treated with semaglutide had a 24% lower risk of a major kidney event, defined as a composite of kidney failure onset (dialysis, transplantation, or an estimated glomerular filtration rate [eGFR]

The results were similar for a composite of only the kidney-specific components of the primary outcome (HR, 0.79) and in terms of cardiovascular mortality (HR, 0.71). 

In further analyses of all confirmatory secondary outcomes, the results continued to favor semaglutide, with the mean annual eGFR slope less steep (indicating a slower decrease) with semaglutide, by 1.16 mL per minute per 1.73 m2 (P <.001 in addition to the risk of major cardiovascular events which were lower with semaglutide p=".029).</p">

The risk of death from any cause was 20% lower with semaglutide versus placebo (HR, 0.80; P=.01). 

“In looking at the components of the primary composite outcome, we see remarkable consistency across all the components, with no suggestion of a differential effect of any of those components,” Perkovic said during his presentation. 

Serious adverse events were also lower in the semaglutide than placebo group (49.6% vs 53.8%).

The results are notable considering that patients with CKD often continue to experience declining kidney function and adverse outcomes despite the reduced cardiovascular risk provided by therapies, Perkovic noted.

“These findings offer great promise in reshaping treatment strategies for individuals at high risk of diabetes-related complications, offering a new avenue for kidney and cardiovascular protection,” he said during his talk.

Results “Reassuring”

Among the important aspects of the study was the high rate of patients receiving cardiovascular treatment, said current ERA President Christoph Wanner, MD, who provided an independent perspective during the session.

“The result that was achieved considering the high saturation of cardiovascular protection used is remarkable,” said Wanner, professor of medicine and head of the Division of Nephrology, University of Würzburg, Germany.

Furthermore, “I have never seen a kidney cohort where up to 80% of subjects [were treated with statins], so I’m happy to see that as well.”

Wanner said the primary endpoint results are “solid and give us the reassurance that we can use this treatment.”

Also providing comment for Medscape Medical News, Alberto Ortiz, MD, PhD, chief of nephrology and Hypertension Renal Unit, Health Research Institute of the Jiménez Díaz Foundation, Madrid, Spain, noted caveats, including the early termination of the trial and that few patients were taking an SGLT2 inhibitor. 

“The number of participants on SGLT2 inhibitors was low and results were nonconclusive for this reason,” he said. Therefore, “this trial does not answer the question of whether semaglutide adds benefit for the primary endpoint for patients who are already on the standard of care, ie, SGLT2 inhibitors.”

The issue was also the first to be raised during the question and answer session, with one audience member asserting that regulatory authorities will argue that SGLT2 inhibitors should be the comparative treatment for GLP-1 receptor agonists.

Perkovic agreed that because of the trial’s timing, the proportion of patients taking an SGLT2 inhibitor was “relatively modest.” However, he added, “I think one of the assumptions is that we have to either choose SGLT2 inhibitors or GLP-1 receptor agonists, and I would challenge that.”

“I think the question is: What benefit do we get when we prescribe [the treatments] in combination? [Ongoing research] is looking at that issue of whether the effects are additive, and we believe they are,” he said. 

Diabetes-Related Kidney Disease: The “Other Pandemic”

As many as 537 million people worldwide have type 2 diabetes. In addition, four out of 10 people with type 2 diabetes and three out of 10 people with type 1 diabetes will develop CKD, Tuttle said.

“Diabetes-related kidney disease is responsible for half of all CKD worldwide — it is the other pandemic,” she said.

She underscored further striking figures: only 7% to 20% of people with CKD are aware that they have the condition.

“Our challenge now is that low CKD awareness, detection, and access to care are major barriers to receiving kidney, heart, and lifesaving therapies,” Tuttle said.

“Effective strategies for therapeutic implementation are urgently needed to improve clinical outcomes in type 2 diabetes and CKD.”

Perkovic has disclosed consulting, advisory, or other relationships with AstraZeneca, Bayer, Boehringer Ingelheim, Chinook, GSK, Jansen, Novo Nordisk, Novartis, Otsuka, Travere, Tricia Pharma, and UpToDate, and is the board director of George Clinical, St. Vincent’s Health Australia, Kidney Health Australia, and several independent medical research institutes. Tuttle has disclosed relationships with AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, ProKidney, and Travere. 

The study was funded by Novo Nordisk. 

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : Medscape – https://www.medscape.com/viewarticle/semaglutide-significantly-improves-chronic-kidney-disease-2024a10009w9

Tags: healthSemaglutidesignificantly
Previous Post

Advisory Panel Votes Against Once-Weekly Insulin for T1D

Next Post

Women’s heart risk spikes after menopause, study shows

ECB’s Lagarde warns of risk to world economy via Trump interference on Fed – Reuters

ECB’s Lagarde warns of risk to world economy via Trump interference on Fed – Reuters

September 1, 2025
The Resilient Engine: Investing in Poland’s Outperforming Economy Amid Global Slowdown – AInvest

The Resilient Engine: Why Investing in Poland’s Booming Economy Is a Smart Move Amid Global Slowdown

September 1, 2025
Country music star apologizes after drunken show ends with cops taking him down: ‘I’m not OK’ – PennLive.com

Country Music Star Apologizes After Drunken Show Ends in Police Intervention: ‘I’m Not OK

September 1, 2025
Arts to promote mental health goal of new University of Michigan clinical program – MLive.com

Innovative University of Michigan Program Harnesses the Arts to Enhance Mental Health

September 1, 2025
Meet the man defending Trump’s political adversaries – ABC News

Meet the man defending Trump’s political adversaries – ABC News

September 1, 2025
Sky High Farm’s Biennial Blends Art, Agriculture and Ecological Urgency – observer.com

Sky High Farm’s Biennial Blends Art, Agriculture and Ecological Urgency – observer.com

September 1, 2025

After 150 Job Applications and Rescinded Offers, Computer Science Grads Face an Unforgiving Job Market

September 1, 2025
Proportion of US students taking chemistry fails to keep pace with other science disciplines – Chemistry World

Why Fewer US Students Are Choosing Chemistry Compared to Other Sciences

September 1, 2025
Going zero-waste for a month opened my eyes — here are 7 lessons I wish I knew sooner – VegOut

7 Eye-Opening Lessons I Learned from Living Zero-Waste for a Month

September 1, 2025
This Secret Technology Will Make The IPhone 17 Super Thin Air – VOI.ID

How This Breakthrough Technology Will Make the iPhone 17 Incredibly Thin and Lightweight

September 1, 2025

Categories

Archives

September 2025
MTWTFSS
1234567
891011121314
15161718192021
22232425262728
2930 
« Aug    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (801)
  • Economy (820)
  • Entertainment (21,700)
  • General (16,798)
  • Health (9,861)
  • Lifestyle (834)
  • News (22,149)
  • People (821)
  • Politics (828)
  • Science (16,030)
  • Sports (21,318)
  • Technology (15,800)
  • World (801)

Recent News

ECB’s Lagarde warns of risk to world economy via Trump interference on Fed – Reuters

ECB’s Lagarde warns of risk to world economy via Trump interference on Fed – Reuters

September 1, 2025
The Resilient Engine: Investing in Poland’s Outperforming Economy Amid Global Slowdown – AInvest

The Resilient Engine: Why Investing in Poland’s Booming Economy Is a Smart Move Amid Global Slowdown

September 1, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version